Skip to main content
    A

    Avalo Therapeutics Inc (AVTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.37
    -0.39 (-5.03%)

    Market Cap: $448.71M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Avalo Therapeutics Inc (AVTX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Avalo Therapeutics are Indaptus Therapeutics (INDP), Alector (ALEC) and Kyverna Therapeutics, Inc. Common Stock (KYTX). By market cap, Avalo Therapeutics ranks 5th of the 13 companies on this page; OmniAb (OABI) is the largest at $716.17M.

    Peer Comparison

    AVTX's revenue growth of -69.3% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Avalo Therapeutics (AVTX)$448.71MN/AN/A0.0%N/A-69.3%0.00%
    Indaptus Therapeutics Inc (INDP)$422.38MN/AN/A0.0%N/A0.0%0.00%
    Alector Inc (ALEC)$378.15M7.3x1.7x23.9%N/A4896.0%0.00%
    Kyverna Therapeutics, Inc. Common Stock (KYTX)$319.27MN/AN/A0.0%-81.5%0.0%0.00%
    Zevra Therapeutics Inc. (ZVRA)$540.30M11.6x3.7x52.8%N/A44.9%0.00%
    Candel Therapeutics Inc (CADL)$486.37MN/AN/A0.0%-43.5%0.0%0.00%
    Larimar Therapeutics Inc (LRMR)$313.73MN/AN/A0.0%N/A0.0%0.00%
    OmniAb Inc. (OABI)$716.17MN/A15.7x-108.1%-17.5%78.3%0.00%
    Gyre Therapeutics Inc. (GYRE)$471.74MN/A3.8x-22.7%N/A0.7%0.00%
    Prelude Therapeutics Inc (PRLD)$275.32MN/A16.3x-269.7%N/A41.0%0.00%
    Prothena Corporation plc (PRTA)$419.01MN/A7.8x-45.4%N/A-74.3%0.00%
    Rezolute Inc (RZLT)$353.54MN/AN/A0.0%N/A0.0%0.00%
    Fulcrum Therapeutics Inc (FULC)$287.96MN/AN/A0.0%N/A-100.0%0.00%
    Peer median$398.58M9.5x5.8x0.0%-43.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Avalo Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Indaptus Therapeutics Inc (INDP)
    Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms.
    INDP competitors
    Alector Inc (ALEC)
    Alector, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of neurodegenerative diseases.
    ALEC competitors
    Kyverna Therapeutics, Inc. Common Stock (KYTX)
    Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health...
    KYTX competitors
    Zevra Therapeutics Inc. (ZVRA)
    Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions...
    ZVRA competitors
    Candel Therapeutics Inc (CADL)
    Candel Therapeutics Inc. is a pioneering biotechnology company focused on revolutionizing cancer treatment through its proprietary oncolytic virus platform...
    CADL competitors
    Larimar Therapeutics Inc (LRMR)
    Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases.
    LRMR competitors
    OmniAb Inc. (OABI)
    OmniAb Inc. is an innovative biotechnology company dedicated to the development of fully human therapeutic antibodies via its advanced OmniAb platform.
    OABI competitors
    Gyre Therapeutics Inc. (GYRE)
    Gyre Therapeutics Inc. is a pioneering biopharmaceutical company at the forefront of developing advanced therapies for rare and complex diseases.
    GYRE competitors
    Prelude Therapeutics Inc (PRLD)
    Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized...
    PRLD competitors
    Prothena Corporation plc (PRTA)
    Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases...
    PRTA competitors
    Rezolute Inc (RZLT)
    Rezolute, Inc., a clinical-stage biopharmaceutical company, develops rare and metabolic disease therapies in the United States.
    RZLT competitors
    Fulcrum Therapeutics Inc (FULC)
    Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined...
    FULC competitors

    Frequently Asked Questions About AVTX

    Who are Avalo Therapeutics' main competitors?

    The companies most similar to Avalo Therapeutics include Indaptus Therapeutics (INDP), Alector (ALEC), Kyverna Therapeutics, Inc. Common Stock (KYTX), Zevra Therapeutics (ZVRA) and Candel Therapeutics (CADL), listed from the closest match.

    Who is Avalo Therapeutics' biggest competitor?

    OmniAb (OABI) is the largest of the similar companies at $716.17M; Indaptus Therapeutics (INDP) is the closest match by business profile, size, sector and industry.

    How does AVTX stock compare with its competitors?

    AVTX's net margin is 0.0% against a peer median of 0.0%.

    Which of Avalo Therapeutics' competitors pays a higher dividend?

    Avalo Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Avalo Therapeutics bigger than its competitors?

    No. Avalo Therapeutics is 5th by market cap among the 13 companies on this page; the largest is OmniAb (OABI) at $716.17M.